Together with his team, Stefan H. E. Kaufmann has advanced the development of a new vaccine against tuberculosis, which could also serve as an interim solution for Covid-19. The infection biologist will continue his research with an emeritus group in Göttingen.
Kaufmann has been researching the pathogens of epidemics such as AIDS, SARS, MERS, and tuberculosis throughout his whole scientific career. For four decades, the tubercle bacillus has been a particular focus of the Max Planck researcher. No other infectious disease kills more people: Last year 10 million people worldwide newly developed tuberculosis disease, and 1.5 million people died from it. It is caused by mycobacteria, which mainly attack…